Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Zanganeh Maky
Relationship:   Chief Executive Office...
City:   Sunnyvale
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   1,125,725    

Indirect Shares

   198,074      
Direct Value   $7,036,769    

Indirect Value

   $1,378,458      
Total Shares   1,323,799      
Total Value   $8,415,227      


Pulse Biosciences, Inc. $4,724,355 Summit Therapeutics Inc $2,312,414 Pulse Biosciences, Inc. $4,724,355 Summit Therapeutics Inc $2,312,414
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    11   
    0    

     Stock price went up :
    10   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   10.0   
   0.0   
     Percentage Gain/Loss :
   62.6%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmacyclics Inc PCYC Chief Operating Officer 2015-05-26 0 2015-05-26 0    Premium*  
            Pulse Biosciences, Inc. PLSE Director 2023-11-13 604,911 2023-11-13 148,074    Premium*  
            Summit Therapeutics Inc SMMT Chief Executive Office... 2024-03-27 520,814 2024-03-27 50,000    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-05-26 4 D $261.25 $20,113,115 I/I (76,988) 0 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-05-26 4 D $261.25 $91,775,296 D/D (351,293) 0 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-05-26 4 D $261.25 $3,918,750 D/D (15,000) 351,293 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2015-03-11 4 S $254.11 $7,623,444 D/D (30,000) 225,312 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-11-12 4 S $137.50 $818,216 D/D (5,931) 210,312 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-11-07 4 S $135.01 $209,401 D/D (1,551) 210,312 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-11-10 4 S $133.50 $3,078,027 D/D (23,000) 210,312 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-09-04 4 S $122.00 $610,000 D/D (5,000) 210,311 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-09-03 4 S $121.10 $850,980 D/D (7,000) 210,311 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2013-12-16 4 S $107.55 $2,151,000 D/D (20,000) 210,107 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-10-31 4 A $80.93 $81 D/D 1 210,312 0 -
PCYC Pharmacyclics Inc Chief Operating Officer   •       –      –    2014-04-30 4 A $80.39 $16,400 D/D 204 210,311 0 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-08-02 4 B $25.15 $208,469 D/D 8,290 287,225 2.39 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-03-17 4 B $24.00 $215,004 I/I 8,960 42,434 2.1 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-12-12 4 B $23.98 $23,979 I/I 1,000 94,474 2.1 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-12-13 4 B $23.98 $26,378 I/I 1,100 95,574 2.1 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-08-03 4 B $23.23 $366,317 D/D 15,500 302,725 2.39 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-08-03 4 B $23.00 $115,015 I/I 5,000 90,474 2.1 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-12-11 4 B $22.76 $68,289 I/I 3,000 93,474 2.1 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-03-20 4 B $22.71 $98,305 I/I 4,280 46,714 2.1 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-03-20 4 B $22.47 $112,360 D/D 5,000 263,935 2.39 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-05-10 4 B $21.71 $108,545 I/I 5,000 85,474 2.1 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-05-11 4 B $20.84 $312,540 D/D 15,000 278,935 2.39 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-05-09 4 B $20.16 $680,500 I/I 33,760 80,474 2.1 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-09-18 4 B $15.02 $116,791 D/D 7,775 332,500 2.39 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us